Let's look at one of the biggest changes in medical practice of the past decade: the decision to stop putting millions of postmenopausal women on hormone replacement therapy, which postulated that replacing the estrogen and progesterone their bodies were no longer making would do them long-term good.

FORBES

Lilly wants to measure the viscosity of postmenopausal women, to see which face the risk of heart disease should they go on estrogen therapy.

FORBES: The Plot Thickens